Suppr超能文献

放射外科治疗脑转移瘤:使用三种分层系统评估患者的适用性

Radiosurgery for treatment of brain metastases: estimation of patient eligibility using three stratification systems.

作者信息

Lorenzoni José, Devriendt Daniel, Massager Nicolas, David Phillippe, Ruíz Salvador, Vanderlinden Bruno, Van Houtte Paul, Brotchi Jacques, Levivier Marc

机构信息

Gamma Knife Center and Department of Neurosurgery, Hôpital Erasme, Route de Lennik 808, Brussels B-1070, Belgium.

出版信息

Int J Radiat Oncol Biol Phys. 2004 Sep 1;60(1):218-24. doi: 10.1016/j.ijrobp.2004.02.017.

Abstract

PURPOSE

To compare three patient stratification systems predicting survival: recursive partitioning analysis (RPA), score index for radiosurgery in brain metastases (SIR), and a proposed basic score for brain metastases (BS-BM).

METHODS AND MATERIALS

We analyzed the outcome of 110 patients treated with Leksell Gamma Knife radiosurgery between December 1999 and January 2003. The BS-BM was calculated by evaluating three main prognostic factors: Karnofsky performance status, primary tumor control, and presence of extracranial metastases.

RESULTS

The median survival was 27.6 months for RPA Class I, 10.7 months for RPA Class II, and 2.8 months for RPA Class III (p <0.0001). Using the SIR, the median survival was 27.7, 10.8, 4.6, and 2.4 months for a score of 8-10, 5-7, 4, and 0-3, respectively (p <0.0001). The median survival was undefined in patients with a BS-BM of 3 (55% at 32 months) and was 13.1 months for a BS-BM of 2, 3.3 months for a BS-BM of 1, and 1.9 months for a BS-BM of 0 (p <0.0001). The backward elimination model in multivariate Cox analysis identified SIR and BS-BM as the only two variables significantly associated with survival (p = 0.031 and p = 0.043, respectively).

CONCLUSION

SIR and BS-BM were the most accurate for estimating survival. They were specific enough to identify patients with short survival (SIR 0-3 and BS-BM 0). Because of it simplicity, BS-BM is easier to use.

摘要

目的

比较三种预测生存的患者分层系统:递归划分分析(RPA)、脑转移瘤放射外科评分指数(SIR)以及一种提议的脑转移瘤基础评分(BS-BM)。

方法和材料

我们分析了1999年12月至2003年1月期间接受Leksell伽玛刀放射外科治疗的110例患者的结局。通过评估三个主要预后因素计算BS-BM:卡诺夫斯基功能状态、原发肿瘤控制情况以及颅外转移的存在情况。

结果

RPA I级患者的中位生存期为27.6个月,RPA II级为10.7个月,RPA III级为2.8个月(p<0.0001)。使用SIR时,评分为8 - 10、5 - 7、4和0 - 3的患者中位生存期分别为27.7、10.8、4.6和2.4个月(p<0.0001)。BS-BM为3的患者中位生存期未定义(32个月时为55%),BS-BM为2的患者中位生存期为13.1个月,BS-BM为1的患者为3.3个月,BS-BM为0的患者为1.9个月(p<0.0001)。多变量Cox分析中的向后消除模型确定SIR和BS-BM是仅有的两个与生存显著相关的变量(分别为p = 0.031和p = 0.043)。

结论

SIR和BS-BM在估计生存方面最为准确。它们足够特异,能够识别生存期短的患者(SIR 0 - 3和BS-BM 0)。由于其简单性,BS-BM更易于使用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验